193 related articles for article (PubMed ID: 20574716)
1. Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.
Sokoro AA; Lepage J; Antonishyn N; McDonald R; Rockman-Greenberg C; Irvine J; Lehotay DC
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S275-81. PubMed ID: 20574716
[TBL] [Abstract][Full Text] [Related]
2. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome in adulthood: a rare recognizable condition.
Filosto M; Alberici A; Tessa A; Padovani A; Santorelli FM
Neurol Sci; 2013 Sep; 34(9):1699-701. PubMed ID: 23247599
[No Abstract] [Full Text] [Related]
3. CUGC for hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
Martinelli D; Fiermonte G; Häberle J; Boenzi S; Goffredo BM; Travaglini L; Agolini E; Porcelli V; Dionisi-Vici C
Eur J Hum Genet; 2020 Jul; 28(7):982-987. PubMed ID: 32242103
[No Abstract] [Full Text] [Related]
4. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Martinelli D; Diodato D; Ponzi E; Monné M; Boenzi S; Bertini E; Fiermonte G; Dionisi-Vici C
Orphanet J Rare Dis; 2015 Mar; 10():29. PubMed ID: 25874378
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of four patients affected by HHH syndrome.
Kim SZ; Song WJ; Nyhan WL; Ficicioglu C; Mandell R; Shih VE
Clin Chim Acta; 2012 Jul; 413(13-14):1151-5. PubMed ID: 22465082
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.
Tessa A; Fiermonte G; Dionisi-Vici C; Paradies E; Baumgartner MR; Chien YH; Loguercio C; de Baulny HO; Nassogne MC; Schiff M; Deodato F; Parenti G; Rutledge SL; Vilaseca MA; Melone MA; Scarano G; Aldamiz-Echevarría L; Besley G; Walter J; Martinez-Hernandez E; Hernandez JM; Pierri CL; Palmieri F; Santorelli FM
Hum Mutat; 2009 May; 30(5):741-8. PubMed ID: 19242930
[TBL] [Abstract][Full Text] [Related]
7. [Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome].
Guan HZ; Ding Y; Li DX; Dong H; Song JQ; Jin Y; Zhu ZJ; Sun LY; Yang YL
Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):428-433. PubMed ID: 28592010
[No Abstract] [Full Text] [Related]
8. Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.
Wang JF; Chou KC
PLoS One; 2012; 7(1):e31048. PubMed ID: 22292090
[TBL] [Abstract][Full Text] [Related]
9. Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.
Silvera-Ruiz SM; Gemperle C; Peano N; Olivero V; Becerra A; Häberle J; Gruppi A; Larovere LE; Motrich RD
Front Immunol; 2022; 13():861516. PubMed ID: 35711415
[TBL] [Abstract][Full Text] [Related]
10. Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy.
Qadri SK; Ting TW; Lim JS; Jamuar SS
Ann Acad Med Singap; 2016 Dec; 45(12):563-566. PubMed ID: 28062886
[No Abstract] [Full Text] [Related]
11. Lactate/pyruvate in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Ono H; Tamada T; Shigematsu Y
Pediatr Int; 2018 Aug; 60(8):762-764. PubMed ID: 30058227
[No Abstract] [Full Text] [Related]
12. Pathogenic potential of SLC25A15 mutations assessed by transport assays and complementation of Saccharomyces cerevisiae ORT1 null mutant.
Marobbio CM; Punzi G; Pierri CL; Palmieri L; Calvello R; Panaro MA; Palmieri F
Mol Genet Metab; 2015 May; 115(1):27-32. PubMed ID: 25818551
[TBL] [Abstract][Full Text] [Related]
13. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome: a treatable genetic liver disease warranting urgent diagnosis.
Lee HH; Poon KH; Lai CK; Au KM; Siu TS; Lai JP; Mak CM; Yuen YP; Lam CW; Chan AY
Hong Kong Med J; 2014 Feb; 20(1):63-6. PubMed ID: 24473688
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: functional analysis of the mutant protein.
Ersoy Tunalı N; Marobbio CM; Tiryakioğlu NO; Punzi G; Saygılı SK; Onal H; Palmieri F
Mol Genet Metab; 2014 May; 112(1):25-9. PubMed ID: 24721342
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15.
Debray FG; Lambert M; Lemieux B; Soucy JF; Drouin R; Fenyves D; Dubé J; Maranda B; Laframboise R; Mitchell GA
J Med Genet; 2008 Nov; 45(11):759-64. PubMed ID: 18978333
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.
Camacho JA; Rioseco-Camacho N; Andrade D; Porter J; Kong J
Mol Genet Metab; 2003 Aug; 79(4):257-71. PubMed ID: 12948741
[TBL] [Abstract][Full Text] [Related]
17. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
Camacho JA; Mardach R; Rioseco-Camacho N; Ruiz-Pesini E; Derbeneva O; Andrade D; Zaldivar F; Qu Y; Cederbaum SD
Pediatr Res; 2006 Oct; 60(4):423-9. PubMed ID: 16940241
[TBL] [Abstract][Full Text] [Related]
18. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with stroke-like imaging presentation: clinical, biochemical and molecular analysis.
Al-Hassnan ZN; Rashed MS; Al-Dirbashi OY; Patay Z; Rahbeeni Z; Abu-Amero KK
J Neurol Sci; 2008 Jan; 264(1-2):187-94. PubMed ID: 17825324
[TBL] [Abstract][Full Text] [Related]
19. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure.
Mhanni AA; Chan A; Collison M; Seifert B; Lehotay DC; Sokoro A; Huynh HQ; Greenberg CR
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):312-5. PubMed ID: 18376250
[TBL] [Abstract][Full Text] [Related]
20. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.
Korman SH; Kanazawa N; Abu-Libdeh B; Gutman A; Tsujino S
J Neurol Sci; 2004 Mar; 218(1-2):53-8. PubMed ID: 14759633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
